This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit September 19, 2014

|Home|   |About the SDSS|   |Join SDSS|   |Member Benefits|   |Bookstore|   |Political Advocacy|  
|National Certification for Skin Care Professionals|   |SDSS Corporate Members|   |Online Continuing Education|




 



Research helps unlock the key to collagen growth, differentiation
Plastic Surgery Practice
New research sheds light on how collagen grows at the molecular level and helps form body structures, ranging from bone, tendon, blood vessels, skin, heart and even corneas. Dr. Wonmuk Hwang, a biomedical engineer at Texas A&M University in College Station, Texas, distinguished molecular-level differences in complex collagen networks formed under different conditions via both a computational model and newly developed computer program.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Research gives LADD a big boost
Plastic Surgery Practice
Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-Aminolevulinic acid (and its methylated ester, methyl aminolevulinate, new research suggests. The findings appear in the August issue of Lasers in Surgery and Medicine. Laser-assisted drug delivery is an evolving technology, which has a potentially wide range of clinical uses that are currently being studied, including the delivery of systemic medications, and potentially stem cells and growth factors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Keytruda: Battling melanoma with new FDA approved drug
News on Wellness
There is good news for people fighting the deadly skin cancer melanoma. Researchers who have spent years working on various melanoma studies are excited about a new drug approved by the United States Food and Drug Administration for treating this deadly form of skin cancer. Called Keytruda (pembrolizumab), this drug is designed to treat patients who have advanced-stage melanoma but who also no longer respond to other drugs for this purpose. This is the first drug approved by the FDA capable of blocking PD-1, a cellular pathway that restricts the immune system from attacking the deadly cancer cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  A Systematic Approach for Brilliant Beauty Results

Formulated to optimize post procedure and home care programs, glo's premium, professional skincare and mineral makeup collections deliver a comprehensive solution for your treatment and retail needs.

www.gloprofessional.com
 


Multifaceted approach effective for facial rejuvenation therapy
Healio
Researchers found that simultaneous extended subsuperficial musculoaponeurotic system rhytidectomy, midface augmentation and full-face erbium: YAG resurfacing provided an effective method for facial rejuvenation among women.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Dendritic cells affect onset and progress of psoriasis
Medical News Today
Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine. The scientists suggest that new strategies to regulate the composition of dendritic cells in psoriatic skin lesions might represent an approach for the future treatment of the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Study: Male pattern baldness tied to prostate cancer
HealthDay News via Doctors Lounge
Men with male pattern baldness may face a higher risk of developing an aggressive type of prostate cancer than men with no balding, a new study suggests. But, the study authors noted that it's not clear yet whether men with this specific pattern of baldness should be concerned.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keywords MALE PATTERN BALDNESS.


Facial melasma and laser treatments
MedEsthetics
A randomized, split-face clinical trial was conducted to compare the safety and efficacy of low-fluence Q-switched Nd:YAG 1,064 nm laser to low-fluence QSAL 755nm laser for the treatment of facial melasma.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Important changes in cellular behavior that occur in rare, blistering skin disease
University at Buffalo via Medical News Today
University at Buffalo researchers and colleagues studying a rare, blistering disease have discovered new details of how autoantibodies destroy healthy cells in skin. This information provides new insights into autoimmune mechanisms in general and could help develop and screen treatments for patients suffering from all autoimmune diseases, estimated to affect 5 to 10 percent of the U.S. population.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  AVANI is the latest in advanced skin-care

Formulated from the very best ingredients that nature has to offer, AVANI's Dead Sea mineral-based products have been enriched with plant extracts, essential oils & vitamins to ensure healthy, radiant skin. AVANI's superb & innovative luxurious range of Dead Sea cosmetics offers you excellence in skin-care.
 


Aesthetic trends among teens
Dermatology Times
Often driven by hormones, social pressure, short-term desires and the belief they’re invincible, teens tend to be challenging patients for physicians who are trying to help, not harm. "Adolescents are actually most similar to perimenopausal women in certain ways because of their fluctuating hormones," says Dr. Vivian Diller, a psychologist based in New York City who works with adolescents and does research on the psychology of beauty and aging.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Early response to oritavancin predicted cure of bacterial skin infections
Healio
An early, positive clinical response to oritavancin within 48 to 72 hours was highly predictive of an eventual cure in adult patients with acute bacterial skin and skin structure infections, according to recent data presented at ICAAC 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Building an aesthetics team (Surgical Aesthetics)
Facial melasma and laser treatments (MedEsthetics)
Zinc supplements and acne treatment (Dr. Bailey Skin Care)
Facial rejuvenation address multiple signs of aging face performed safely at 1 time (Medical College of Georgia at Georgia Regents University via News-Medical.Net)

Don't be left behind. Click here to see what else you missed.


Want to be published?
MultiBriefs
In an effort to enhance the overall content of Warfield Weekly Update, we'd like to include peer-written articles in future editions. As a member of SDSS, your knowledge and experience in the industry can be of great help to your fellow members. And we're hoping you'll share this expertise with your peers through well-written commentary. Because of the digital format, there's no word or graphical limit, and our group of talented editors can help with final edits. If you're interested in participating, please contact Ronnie Richard to discuss logistics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Model is transformed with prosthetic acne to understand her sister's severe acne
The Gloss
This model's reaction to her transformation, helps us all understand what it's like to suffer from acne, it can be difficult to fully understand what it's like.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Experts clarify verrucous hemangioma confusion
Dermatology Times
The diagnosis of angiokeratoma circumscriptum should be supplanted with verrucous hemangioma, and the lesion should be treated with surgery in most cases, according to a retrospective case series presented at the annual meeting of the Canadian Dermatology Association.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Viewpoint: Are hyperpigmentation treatments doing more harm than good?
Skin Inc.
This article addresses the common misconceptions about the role of age spots, liver spots and melasma, and offers new ways to correct these issues without compromising the health of the skin.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


 Member Benefit


What is your Membership Worth?
      Answer: More than double what you invest!


As an SDSS member, you are eligible to save on Incorporation and full-range of business solutions — VCorp. Sign up here. This is a $30 value.


NOT A MEMBER — Join Now!


 Continuing Education
COA-Approved Webinar

Let the Light Shine On! Entering the Light Therapy Markete

Presented by Kate Riley

About the webinar:
This presentation will provide an introduction into phototherapy for the skin care specialist who is not presently offering this procedure. We will discuss the underlying theory of light-based therapy; the differences in how light is generated and the benefits and limitations of each type of modality. 1.0 CE through March 8, 2017.

At the conclusion of this presentation the skin care specialist will be able to:
1) Summarize basic phototherapy theory.
2) Discuss the differences in light-based modalities.
3) Compare Laser, Intense Pulsed Light (IPL), and Light Emitting Diodes (LED).
4) Evaluate if phototherapy can work in their practice..

Webinar cost: $19.95 member; $24.95 nonmember. To order this webinar as a member, click here. To order this webinar as a nonmember, click here.

Important! Once purchased, the webinar link will only be valid for 24 hours.

View other COA-Approved Continuing Education


The NCEA Commission on Accreditation has approved these webinars. For more information on the Commission on Accreditation go to NCEA Certified website.

NOT A MEMBER — Join Now!



Susanne S. Warfield, President/CEO of Paramedical Consultants, Inc. (www.PCIJournal.com) Official Publication of the Society of Dermatology SkinCare Specialists. Warfield has more than 33 years' experience, is a leading expert on business, legal and liability issues that affect physician and esthetician relationships. She has authored more than 450 articles and 15 books for the consumer, medical and skin care sectors. She is the recipient of the prestigious Crystal Award for Life Achievement by Les Nouvelles Esthétiques & Spa.More

                    



 

Warfield Weekly Update
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Rebecca Eberhardt, Content Editor, 469.420.2608   
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of Warfield Weekly Update was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 12, 2014
Sept. 5, 2014
Aug. 29, 2014
Aug. 15, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063